LP135651-0
Dabigatran
Active
Description
Dabigatran (marketed as Pradaxa in Australia, Europe and USA, Pradax in Canada, and Prazaxa in Japan) is an anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require frequent blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia
Basic Part Properties
- Part Display Name
- Dabigatran
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2011-09-30
- Construct for LOINC Short Name
- Dabigatran
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP135651-0 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP135651-0
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 达比加群 Synonyms: 达比加群酯; |
fr-CA | French (Canada) | Dabigatran |
es-ES | Spanish (Spain) | Dabigatran |
it-IT | Italian (Italy) | Dabigatran |
tr-TR | Turkish (Turkey) | Dabigatran |
ru-RU | Russian (Russian Federation) | Дабигатран |
nl-NL | Dutch (Netherlands) | dabigatran |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright